The observation of a decline in T cell expansion in nanovaccine immunized mice, when comparing 21 days vs. 10 days pi (Figure S2A), indicates that the proliferation time of effector phenotypes of both CD4+ and CD8+ T cells occurred early on and this vaccine composition reduced the time required for better resolution of infection. This evidence concerns the gene CD8A and infection.